We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-8.81%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$369M
AUM Growth
-$22.3M
Cap. Flow
+$15.3M
Cap. Flow %
4.14%
Top 10 Hldgs %
67.81%
Holding
26
New
2
Increased
14
Reduced
8
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 87.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THOR
26
DELISTED
THORATEC CORPORATION
THOR
-229,300
Closed -$10.2M

Similar funds

Sector Gamma AS's Q3 2015 Portfolio in Review

As of Q3 2015, Sector Gamma AS held 26 positions worth $369M, down 5.7% from $392M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Sector Gamma AS deployed $15.3M of net new capital in Q3 2015, opening 2 new positions and adding to 14 existing holdings. Its largest new stake was BAXALTA INC COM STK (DE): 892,200 shares worth $28.1M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 90% a quarter earlier.

On the sell side, the largest reduction was Baxter International, an estimated $17.9M trimmed.

  • Sector Gamma AS's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 892,200 shares worth $28.1M.
  • Sector Gamma AS added most to Johnson & Johnson in Q3 2015, an estimated $12.8M increase.
  • Sector Gamma AS's biggest Q3 2015 reduction was Baxter International, cutting an estimated $17.9M.
  • Sector Gamma AS fully exited Teva Pharmaceuticals in Q3 2015, selling an estimated $15.5M.
  • Sector Gamma AS's ten largest holdings make up 68% of its $369M portfolio in Q3 2015.
  • Sector Gamma AS opened 2 new positions and closed 2 in Q3 2015.
  • Sector Gamma AS's portfolio value fell 5.7% quarter-over-quarter to $369M.

Based on Sector Gamma AS's 13F filing for Q3 2015, filed 16 Nov 2015.